Willkommen, Generic Plavix!

Sometimes selling a $7 billion blood thinner sounds like more trouble than it’s worth. Bristol-Myers Squibb and Sanofi-Aventis just finished cleaning up the mess from botched negotiations trying to keep generic Plavix off the market in the U.S. Today, word comes out of the blue that a copycat version of the drug from a Swiss [...]